Journal article icon

Journal article

Anti-cytokine therapy for rheumatoid arthritis.

Abstract:

Tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1) are important in mediating inflammation in rheumatoid arthritis (RA). Randomized phase II and III clinical trials of anti-TNF reagents (infliximab and etanercept) have demonstrated an acceptable safety profile and marked clinical efficacy in cases of RA that have not responded adequately to conventional therapy. Combination therapy with methotrexate (MTX) appears to be particularly effective in patients whose disease activity pe...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
Journal:
Annual review of medicine
Volume:
51
Issue:
1
Pages:
207-229
Publication date:
2000
DOI:
EISSN:
1545-326X
ISSN:
0066-4219
URN:
uuid:2836f6f4-7265-4ce2-8cf7-933e598904a2
Source identifiers:
226919
Local pid:
pubs:226919

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP